PDCD1 and neoplasm: Compared to the FMT control+anti-PD1 group, the anti-tumor activity of anti-PD1 was intensively activated in the FMT SCP+anti-PD1 group, resulting in a tumor size reduction from 1112.25 mm3 to 750.34 mm3 (Figure 4B).